Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Interest & Investment Income readings, the most recent being $527000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 41.38% to $527000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 43.06% decrease, with the full-year FY2025 number at $2.8 million, down 43.06% from a year prior.
  • Interest & Investment Income hit $527000.0 in Q4 2025 for Treace Medical Concepts, down from $634000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.0 million in Q2 2023 to a low of -$1000.0 in Q1 2021.
  • Median Interest & Investment Income over the past 5 years was $764000.0 (2022), compared with a mean of $785400.0.
  • Biggest five-year swings in Interest & Investment Income: crashed 103.03% in 2021 and later skyrocketed 16333.33% in 2023.
  • Treace Medical Concepts' Interest & Investment Income stood at $5000.0 in 2021, then skyrocketed by 14960.0% to $753000.0 in 2022, then skyrocketed by 126.96% to $1.7 million in 2023, then crashed by 47.4% to $899000.0 in 2024, then plummeted by 41.38% to $527000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $527000.0 (Q4 2025), $634000.0 (Q3 2025), and $775000.0 (Q2 2025) per Business Quant data.